Navigation Links
Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013
Date:10/27/2013

SAN DIEGO, Oct. 27, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced several significant clinical data presentations and other activities related to its physiology and Intravascular Ultrasound (IVUS) technologies at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, being held in San Francisco from October 27 to November 1.

The data include final results from the ADVISE II (ADenosine Vasodilator Independent Stenosis Evaluation) Registry, which will be presented in a Late-Breaking Clinical Trials session on October 30. The prospective, 40-center, global registry evaluated the diagnostic utility of a combined instant wave-Free Ratio™ (iFR®)1 and Fractional Flow Reserve (FFR) workflow to reduce the need for hyperemic agents in patients with intermediate or unclear lesions. Additionally, a first look at two-year outcomes from an analysis of use of IVUS in the ADAPT-DES Study, the largest prospective registry of IVUS use to date, will be presented in an oral session. This registry of more than 8,000 patients evaluated the use of IVUS in placing the current generation of drug-eluting stents and its ability to reduce stent thrombosis and impact other clinical outcomes. 

"FFR, iFR and IVUS are technologies that we believe can improve both appropriateness and quality in the diagnosis and treatment of coronary and peripheral vascular disease. However, they are not used as often as they could be," said Scott Huennekens, president and chief executive officer of Volcano Corp. "The new data being presented at TCT 2
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  Nektar Therapeutics (Nasdaq: NKTR ... ended June 30, 2014 on Thursday, July 31, 2014, after ... president and chief executive officer, will host a conference call ... (ET)/2:00 p.m. Pacific Time (PT). The press ... can be accessed through a link that is posted on ...
(Date:7/22/2014)... NASHVILLE, Tenn. , July 22, 2014 ... will release second quarter 2014 financial results after the ... call and live Internet webcast will be held on ... to discuss the results. To participate in ... 253-237-1032 (for international callers).  A rebroadcast of the teleconference ...
(Date:7/22/2014)... Research and Markets has announced the addition ... Reagent, by Application - Global Forecast to 2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals are pharmaceutical products isolated ... most important and widely used techniques for biopharmaceutical production. ... cell culture market in 2013. Growth in the biopharmaceutical ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3
(Date:7/22/2014)... 22, 2014 The 2014 Warrior-Family ... Ronald Reagan Building and International Trade Center in ... Families and Civilian Communities,” will be held from ... 7:30 a.m.) and cohosted by the Military Officers ... Industrial Association (NDIA). USAA is the Executive Sponsor ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Aaron Marshall, Corporate ... The Hearing and Speech Agency for the 2014-2015 ... Of his appointment, Marshall states, "“Serving on the HASA ... others are living and helps me remember how much others ... of Law graduate, Aaron also has a B.S. in Finance ...
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... treatments that break up blood clots deep in the veins ... risk. However, one results in a greater risk of bleeding ... of the other treatment, a new study finds. The ... thrombosis (DVT) -- is blood-thinning medications and compression stockings. The ...
(Date:7/22/2014)... July 22, 2014) The American Society of ... the University of California Los Angeles with the ... in iron homeostasis, including the discovery of the iron-regulatory ... metabolism. This award, named after the Nobel Prize Laureate ... pioneering research achievements in hematology that have represented a ...
(Date:7/22/2014)... using electric power morcellation, uterine cancers were present in ... procedure, according to a study published by JAMA ... which the uterus is fragmented into smaller pieces, may ... the commercial availability of electric power morcellators for 2 ... the time of electric power morcellation (in this study ...
Breaking Medicine News(10 mins):Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 2Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 3Health News:New Board President for Baltimore-based Nonprofit 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 3Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:Study examines presence of uterine cancers at the time of hysterectomy using morcellation 2
... A five year study undertaken by the King’s College, ... leading to premature death in many people//. This study ... ,According to this research, continued use of sedatives called ... people suffering from Alzheimer's and other types of dementia. ...
... The impact of exercise on body fat differs for boys and ... of Sports Medicine. ,Recommendations on exercise to curb the ... unisex approach, say the authors. ,The findings are based ... 10 at 12 schools in the Republic of Ireland. ...
... March 29 (DPA) A Serbian patient has survived more than ... the Belgrade daily Blic reported Thursday.// ,The gauze ... ago, a spokesman of the Sremska Kamenica cardiovascular institute, 70 ... ,It was found during surgery in mid-March. The latter ...
... died in Indonesia after apparently contracting the lethal H5N1 strain ... ,A preliminary test has revealed the presence of the ... West Sumatra and a 28-year-old woman from Jakarta. ... released. If they confirm the initial test results, Indonesia's death ...
... in blindness among children in a big way in the North ... ,As much as 51.6 per cent of the children in ... over a period of time only because of vitamin-related problems. Effective ... the poor of the North East, a study reveals. ,There is ...
... overweight men who are diagnosed with prostate cancer by biopsy ... a more aggressive// case of the disease than the biopsy ... Duke University Medical Center researcher. ,The finding suggests ... overweight men to receive inadequate or inappropriate treatment that is ...
Cached Medicine News:Health News:Alzheimer's Drugs Lead To Early Deaths 2Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 2Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 3
... 3730xl DNA Analyzer reduces the time, cost, ... Higher optical sensitivity and advanced polymers enable ... less. , Multiple automation features decrease costly ... productivity without compromising your results. , Perform ...
This unique kit contains three pipettes conveniently packaged with useful accessoriesat an economical price....
... test is an immunochromatography based one ... for qualitative determination of Phencyclidine in ... of 25 ng/mL. This assay has ... of care location,and is for use ...
... test is an immunochromatography based one ... for qualitative determination of Methamphetamine in ... of 1000 ng/mL. This assay has ... of care,location and is for use ...
Medicine Products: